Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction

Circulation: Cardiovascular Imaging

Volumn 5, Issue 1, 2012, Pages 127-136

  Desjardins, Candida L ^a   Chen, Yong ^b   Coulton, Arthur T ^a   Hoit, Brian D ^a   Yu, Xin ^a,b   Stelzer, Julian E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cardiomyopathy; Mechanics; MRI; Myocardial contraction

Indexed keywords

MESSENGER RNA; MYOSIN BINDING PROTEIN C; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIASTOLE; GENE MUTATION; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE WALL MOTION; HYPERTROPHIC CARDIOMYOPATHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLE; TORSION; WILD TYPE; ANIMAL; DISEASE MODEL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; HEART VENTRICLES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MYOCARDIAL CONTRACTION; VENTRICULAR FUNCTION, LEFT;

EID: 84858304582     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.965772     Document Type: Article

References (48)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in the general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study: Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-789.
2. Carrier L. Cardiac myosin-binding protein C in the heart. Arch Mal Coeur Vaiss. 2007;100:238-243. (Pubitemid 46648955)
3. Barefield D, Sadayappan S. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol. 2010;48:866-875.
4. Harris SP, Lyons RG, Bezold KL. In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res. 2011;108:751-764.
5. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
6. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
7. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:2125-2132. (Pubitemid 39576030)
8. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257. (Pubitemid 28216578)
9. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagége AA, Trent RJ, Komajda M, Fiszman M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 1997;80:427-434. (Pubitemid 27093358)
10. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kübler W, Katus HA. Novel splice donor site mutation in the cardiac myosin binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest. 1997;100:475-482. (Pubitemid 27349096)
11. Moolman JA, Reith S, Uhl K, Bailey S, Gautel M, Jeschke B, Fischer C, Ochs J, McKenna WJ, Klues H, Vosberg HP. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation. 2000;101:1396-1402. (Pubitemid 30169861)
12. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: Haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation. 2009;119:1473-1483.
13. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res. 2009;105:219-222.
14. Jacques A, Hoskins AC, Kentish JC, Marston SB. From genotype to phenotype: A longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene. J Muscle Res Cell Motil. 2008;29:239-246.
15. Schlossarek S, Mearini G, Carrier L. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities. J Mol Cell Cardiol. 2011;50:613-620.
16. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res. 2002;90:594-601. (Pubitemid 34640910)
17. Palmer BM, Georgakopoulos D, Janssen PM, Wang Y, Alpert NR, Belardi DF, Harris SP, Moss RL, Burgon PG, Seidman CE, Seidman JG, Maughan DW, Kass DA. Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ Res. 2004;94:1249-1255. (Pubitemid 38656412)
18. Nagayama T, Takimoto E, Sadayappan S, Mudd JO, Seidman JG, Robbins J, Kass DA. Control of in vivo left ventricular contraction/relaxation kinetics by myosin binding protein C: Protein kinase A phosphorylation dependent and independent regulation. Circulation. 2007;116:2399-2408. (Pubitemid 350145075)
19. Carrier L, Knöll R, Vignier N, Keller DI, Bausero P, Prdhon B, Isnard R, Ambroisine ML, Fiszman M, Ross J Jr, Schwartz K, Chien KR. Asymetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res. 2004;63:293-304. (Pubitemid 38900843)
20. Chen Y, Somji A, Yu X, Stelzer JE. Altered in vivo left ventricular torsion and principal strains in hypothyroid rats. Am J Physiol Heart Circ Physiol. 2010;299:H1577-H1587.
21. Stelzer JE, Larsson L, Fitzsimons DP, Moss RL. Activation dependence of stretch activation in mouse skinned myocardium: Implications for ventricular function. J Gen Physiol. 2006;127:95-107. (Pubitemid 43177133)
22. Stelzer JE, Patel JR, Walker JW, Moss RL. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res. 2007;101: 503-511. (Pubitemid 47347881)
23. Liu W, Ashford MW, Chen J, Watkins MP, Williams TA, Wickline SA, Yu X. MR tagging demonstrates quantitative differences in regional ventricular wall motion in mice, rats, and men. Am J Physiol Heart Circ Physiol. 2006;291:H2515-H2521.
24. Zhong J, Liu W, Yu X. Characterization of three-dimensional myocardial deformation in the mouse heart: An MR tagging study. J Magn Reson Imaging. 2008;27:1263-1270. (Pubitemid 351770676)
25. Stelzer JE, Fitzsimons DP, Moss RL. Ablation of myosin binding protein-C accelerates force development in mouse myocardium. Biophys J. 2006;90:4119-4127. (Pubitemid 43846126)
26. Palmer BM, Noguchi T, Wang Y, Heim JR, Alpert NA, Burgon PG, Seidman CE, Seidman JG, Maughan DW, LeWinter MM. Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. Circ Res. 2004;94:1615-1622. (Pubitemid 38856969)
27. Colson BA, Bekyarova T, Fitzsimons DP, Irving TC, Moss RL. Radial displacement of myosin cross-bridges in mouse myocardium due to ablation of myosin binding protein-C. J Mol Biol. 2007;367:36-41. (Pubitemid 46274721)
28. Theis JL, Bos JM, Theis JD, Miller DV, Dearani JA, Schaff HV, Gersh BJ, Ommen SR, Moss RL, Ackerman MJ. Expression patterns of cardiac myofilament proteins: Genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. Circ Heart Fail. 2009;2:325-333.
29. McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG. Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res. 2001;88:383-389. (Pubitemid 32200110)
30. Kim D, Gilson WD, Kramer CM, Epstein FH. Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: Development and initial evaluation. Radiology. 2004;230:862-871. (Pubitemid 38252888)
31. Gilson WD, Yang Z, French BA, Epstein FH. Complementary displacement-encoded MRI for contrast-enhanced infarct detection and quantification of myocardial function in mice. Magn Reson Med. 2004; 51:744-752. (Pubitemid 38420451)
32. Streeter DD Jr, Spotnitz HM, Patel DP, Ross J Jr, Sonnenblick EH. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res. 1969;24:339-347.
33. Wang TT, Kwon HS, Dai G, Wang R, Mijailovich SM, Moss RL, So PTC, Wedeen VJ, Gilbert RJ. Resolving myoarchitectural disarray in the mouse ventricular wall with diffusion spectrum magnetic resonance imaging. Ann Biomed Eng. 2010;38:2841-2450.
34. Taber LA, Ming Y, Podszus WW. Mechanics of ventricular torsion. J Biomech. 1996;29:745-752. (Pubitemid 26137409)
35. Sengupta PP, Tondato F, Khanderia BK, Belohavek M, Jahangir A. Electromechanical activation sequence in normal heart. Heart Failure Clin. 2008;4:303-314. (Pubitemid 351888383)
36. Germans T, Rüssel IK, Götte MJ, Spreeuwenberg MD, Doevendans PA, Pinto YM, van der Geest RJ, van der Velden J, Wilde AA, van Rossum AC. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:13.
37. Ennis DB, Epstein FH, Kellman P, Fananapazir L, McVeigh ER, Arai AE. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med. 2003; 50:638-642. (Pubitemid 37082091)
38. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Køber L. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009;2:314-321.
39. Doucende G, Schuster I, Rupp T, Startun A, Dauzat M, Obert P, Nottin S. Kinetics of left ventricular strains and torsion during incremental exercise in healthy subjects: The key role of torsional mechanics for systolic-diastolic coupling. Circ Cardiovasc Imaging. 2010;3:586-594.
40. Carasso S, Yang H, Woo A, Jamorski M, Wigle ED, Rakowski H. Diastolic myocardial mechanics in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23:164-171.
41. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol. 2003;41:1776-1782. (Pubitemid 36584252)
42. Timmer SA, Germans T, Götte MJ, Rüssel IK, Dijkmans PA, Lubberink M, ten Berg JM, ten Cate FJ, Lammertsma AA, Knaapen P, van Rossum AC. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2010; 37:779-788.
43. Eijssen LM, van den Bosch BJ, Vignier N, Lindsey PJ, van den Burg CM, Carrier L, Doevendans PA, van der Vusse GJ, Smeets HJ. Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice. Genomics. 2008;91:52-60.
44. Morita H, Nagai R, Seidman JG, Seidman CE. Sarcomere gene mutations in hypertrophy and heart failure. J Cardiovasc Transl Res. 2010;3: 297-303.
45. Kaski JP, Syrris P, Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliott PM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009;2:436-441.
46. Rodríguez-García MI, Monserrat L, Ortiz M, Fernández X, Cazón L, Núñez L, Barriales-Villa R, Maneiro E, Veira E, Castro-Beiras A, Hermida-Prieto M. Screening mutations in myosin binding protein C3 gene in a cohort of patients with hypertrophic cardiomyopathy. BMC Med Genet. 2010;11:67.
47. Maron MS. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy. J Cardiovasc Trans Res. 2009;2:415-425.
48. Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H. Systolic myocardial mechanics in hypertrophic cardiomyopathy: Novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21:675-683.